Poor adherence to therapies costs two billion a year, AIFA’s Working Group on Precision Medicine and Prescriptomics kicks off to improve it

News Healthcare & Pharma General Updates

Date: 11th Nov, 2024 Source: Italian Medicines Agency (AIFA) Country: Italy Original Source

Brief

On "11/11/2024", the "Italian Medicines Agency (AIFA)" issued an update regarding "Poor adherence to therapies costs two billion a year, AIFA's Working Group on Precision Medicine and Prescriptomics kicks off to improve it". The Italian Medicines Agency has launched a working group to tackle poor adherence to therapies, which costs around 2 billion euros annually. The initiative aims to optimize medication use through precision medicine and AI-powered solutions, ultimately improving patient outcomes and reducing healthcare costs.

This content is restricted.

Highlights content goes here...

This content is restricted.

Italian Medicines Agency (AIFA)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Poor adherence to therapies costs two billion a year, AIFA’s Working Group on Precision Medicine and Prescriptomics kicks off to improve it

Brief

Italian Medicines Agency (AIFA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Poor adherence to therapies costs two billion a year, AIFA’s Working Group on Precision Medicine and Prescriptomics kicks off to improve it

Brief

Italian Medicines Agency (AIFA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.